2,320 Stryker Corporation $SYK Shares Sold by Trillium Asset Management LLC

Trillium Asset Management LLC lessened its holdings in shares of Stryker Corporation (NYSE:SYK – Free Report) by 3.2% during the third quarter, HoldingsChannel.com reports. The firm owned 69,671 shares of the medical technology company’s stock after selling 2,320 shares during the quarter. Trillium Asset Management LLC’s holdings in Stryker were worth $19,188,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds also recently made changes to their positions in SYK. International Assets Investment Management LLC grew its holdings in shares of Stryker by 1,432.8% during the 3rd quarter. International Assets Investment Management LLC now owns 25,000 shares of the medical technology company’s stock worth $6,885,000 after purchasing an additional 23,369 shares in the last quarter. Amundi increased its position in shares of Stryker by 18.3% in the second quarter. Amundi now owns 1,246,353 shares of the medical technology company’s stock worth $392,402,000 after purchasing an additional 192,447 shares during the period. The Manufacturers Life Insurance Company increased its position in shares of Stryker by 8.2% in the second quarter. The Manufacturers Life Insurance Company now owns 859,544 shares of the medical technology company’s stock worth $270,642,000 after purchasing an additional 65,333 shares during the period. Veritas Asset Management LLP acquired a new position in Stryker in the second quarter valued at about $168,057,000. Finally, Bank of America Corp DE acquired a new position in Stryker in the second quarter valued at about $1,404,284,000. 77.09% of the stock is owned by institutional investors.

Insiders Place Their Bets

In related news, Director Ronda E. Stryker sold 550,000 shares of Stryker stock in a transaction that occurred on Friday, November 6th. The shares were sold at an average price of $325.32, for a total transaction of $178,926,000.00. Following the sale, the director directly owned 1,701,375 shares of the company’s stock, valued at approximately $553,491,315. The trade was a 24.43% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, insider Debra King sold 826 shares of the company’s stock in a transaction that occurred on Tuesday, August 18th. The stock was sold at an average price of $336.30, for a total transaction of $277,783.80. Following the transaction, the insider owned 6,210 shares of the company’s stock, valued at approximately $2,088,423. This represents a 11.74% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Over the last 90 days, insiders sold 901,267 shares of company stock valued at $297,123,701. 4.60% of the stock is currently owned by corporate insiders.

Stryker Price Performance

Shares of Stryker stock traded down $3.34 during trading on Friday, reaching $309.05. 3,251,740 shares of the company’s stock were exchanged, compared to its average volume of 3,235,306. The company has a debt-to-equity ratio of 0.60, a quick ratio of 1.30 and a current ratio of 2.18. Stryker Corporation has a 1-year low of $267.00 and a 1-year high of $389.33. The company has a market cap of $117.65 billion, a P/E ratio of 32.91, a PEG ratio of 2.14 and a beta of 0.78. The firm’s 50-day moving average price is $292.30 and its 200 day moving average price is $322.60.

Stryker (NYSE:SYK – Get Free Report) last released its quarterly earnings data on Thursday, October 29th. The medical technology company reported $3.52 earnings per share for the quarter, missing the consensus estimate of $3.55 by ($0.03). Stryker had a net margin of 13.78% and a return on equity of 23.74%. The business had revenue of $6.52 billion during the quarter, compared to analyst estimates of $6.62 billion. During the same period last year, the business earned $3.19 earnings per share. The business’s quarterly revenue was up 7.6% compared to the same quarter last year. As a group, research analysts anticipate that Stryker Corporation will post 14.85 earnings per share for the current year.

Wall Street Analyst Weigh In

Several equities research analysts recently weighed in on the stock. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Stryker in a research report on Thursday, October 29th. BTIG Research dropped their target price on shares of Stryker from $316.00 to $304.00 and set a “buy” rating for the company in a research report on Friday, October 30th. Piper Sandler upped their price target on shares of Stryker from $325.00 to $350.00 and gave the stock an “overweight” rating in a report on Monday, November 9th. Barclays cut their price target on shares of Stryker from $375.00 to $365.00 and set an “overweight” rating for the company in a report on Friday, October 30th. Finally, BMO Capital Markets reiterated an “outperform” rating and set a $309.00 price target (down from $317.00) on shares of Stryker in a research report on Friday, October 30th. Twenty-one equities research analysts have rated the stock with a Buy rating and seven have given a Hold rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $342.19.

Check Out Our Latest Stock Report on SYK

Stryker Company Profile

(Free Report)

Stryker is a medical technology company that develops and sells products and services for healthcare providers. Its offerings include orthopedic implants and surgical equipment, neurotechnology and spine products, and medical and surgical equipment used in hospitals and other care settings. The company’s products also include patient-handling and emergency medical equipment, as well as instruments and technologies that support surgical procedures. Stryker serves healthcare customers in the United States and internationally.

Recommended Stories

Want to see what other hedge funds are holding SYK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Stryker Corporation (NYSE:SYK – Free Report).

Institutional Ownership by Quarter for Stryker (NYSE:SYK)

Receive News & Ratings for Stryker Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stryker and related companies with MarketBeat.com's FREE daily email newsletter.